Evolve or Die. The biosimilar concept is at a crossroads. In this BASG discussion, we explain what needs to change to make the concept fit for the future.
Contents
- Cutting-edge topics in both regulatory and medical terms
- A controversial reflection paper
- Exchange of experiences and discussion
Target group
- Employees of authorisation and access departments
- Employees of consulting companies in the pharmaceutical industry
Language
German
Registration information
Please register by 27.02.2025 at the latest.
This event will be held as an online-only event .
Technical management
Dr Gerhard Beck
Institute for Assessment and Analysis
Medical Market Surveillance Business Unit, AGES GmbH